Multi-class subarachnoid hemorrhage severity prediction: addressing challenges in predicting rare outcomes.

Journal: Neurosurgical review
Published Date:

Abstract

Accurately predicting the severity of subarachnoid hemorrhage (SAH) is critical for informing clinical decisions and improving patient outcomes. This study addresses the challenges of imbalanced data in SAH severity classification by employing the Modified Rankin Scale (MRS) within a three-stage classification framework. We utilize a three-stage approach to effectively categorize SAH severity. In the first stage, we performed binary classification, grouping SAH severity into "Good Outcome" (class 0), which includes MRS levels 0, 1, 2, and 3, and "Poor Outcome" (class 1), encompassing levels 4, 5, and 6. Feature selection was done using a Random Forest algorithm to identify the top 20 features for the SAH severity prediction. We evaluated thirteen machine learning models at each stage, selecting the top-performing classifiers to optimize results. The dataset comprised 535 samples across seven MRS severity levels and was validated using 5-fold cross-validation and diverse subgroups to ensure robust model performance across various scenarios. Binary classification in the first stage achieved approximately 90% accuracy with Extra Trees. In the second stage, targeting the "Good Outcome" group, the Random Forest model reached 88% accuracy, while in the third stage, it achieved 86% accuracy for the "Poor Outcome" group. By increasing accuracy across unbalanced classes and emphasizing its potential for practical use, the multi-stage technique presents a promising solution for predicting the severity of SAH. Future research will concentrate on additional tuning to improve the model's efficacy in actual healthcare environments.

Authors

  • Muhammad Mohsin Khan
    Department of Neurosurgery, Hamad General Hospital, Doha, Qatar.
  • Adiba Tabassum Chowdhury
    Department of Electrical and Electronics Engineering, University of Dhaka, Dhaka, Bangladesh.
  • Md Shaheenur Islam Sumon
    Department of Biomedical Engineering, Military Institute of Science and Technology (MIST), Dhaka 1216, Bangladesh.
  • Shaikh Nissaruddin Maheboob
    Department of Surgical Intensive Care Unit, Hamad Medical Corporation, Doha, Qatar.
  • Arshad Ali
    Neurosurgery Department, Hamad Medical Corporation, Doha, Qatar.
  • Abdul Nasser Thabet
    Neurosurgery Department, Hamad Medical Corporation, Doha, Qatar.
  • Ghaya Al-Rumaihi
    Neurosurgery Department, Hamad Medical Corporation, Doha, Qatar.
  • Sirajeddin Belkhair
    Neurosurgery Department, Hamad General Hospital, Qatar; Department of Clinical Academic Sciences, College of Medicine, Qatar University, Doha, Qatar; Department of Neurological Sciences, Weill Cornell Medicine, Doha, Qatar.
  • Ghanem AlSulaiti
    Neurosurgery Department, Hamad Medical Corporation, Doha, Qatar.
  • Ali Ayyad
    Department of Neurosurgery, Saarland University Hospital, Homburg, Germany; Department of Neurosurgery, Hamad General Hospital, Doha, Qatar.
  • Noman Shah
    Neurosurgery Department, Abbottabad Medical Complex, Pakistan.
  • Anwarul Hasan
    Department of Mechanical and Industrial Engineering, College of Engineering, Qatar University, Doha 2713, Qatar.
  • Shona Pedersen
    Medical Science College of Medicine, Qatar University, Doha, Qatar. spedersen@qu.edu.qa.
  • Muhammad E H Chowdhury
    Department of Electrical Engineering, Qatar University, Doha 2713, Qatar.